Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Curtis

Showing results (651-660 of 675) with videos related to

Pageof 68
Sort By:
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
The New England Journal of Medicine|October 22, 2019
Metoprolol for the Prevention of Acute Exacerbations of COPDMark T Dransfield, Helen Voelker, Surya P Bhatt, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
Journal of General Internal Medicine|April 18, 2023
Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort StudyElizabeth A Regan, Melissa E Lowe, Barry J Make, et al.
JAMA|August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryWilliam McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society|September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS CohortDaniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Pageof 68

Showing results (651-660 of 675) with videos related to

Sort By:
Pageof 68
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
The New England Journal of Medicine|October 22, 2019
Metoprolol for the Prevention of Acute Exacerbations of COPDMark T Dransfield, Helen Voelker, Surya P Bhatt, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
Journal of General Internal Medicine|April 18, 2023
Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort StudyElizabeth A Regan, Melissa E Lowe, Barry J Make, et al.
JAMA|August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryWilliam McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society|September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS CohortDaniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Pageof 68